Healthy diet may reduce the risk of low‐grade prostate cancer progressing to a higher grade

assess patients for signs, symptoms, and risks of this approach and engage in shared decision-making to allow patients to participate in their treatment plan and raise any concerns.Given that hematologic toxicity, mainly neutropenia, was more common during chemoradiotherapy in patients who first received induction chemotherapy, Dr McCormack emphasizes the importance of closely monitoring patients during induction chemotherapy for hematologic toxicity and initiating treatment with growth factors when indicated.